Research Archive — Page 1 of 136

(iStock)
August 28, 2026

Mild cognitive impairment’s impact on postsurgical pain is focus of $3.2 million grant

At least 11% of older surgical patients — roughly 3 million people annually — have MCI, a condition linked to progression to Alzheimer’s disease.

A. Compared to healthy individuals, psychosis subtype 1 demonstrated significantly larger surface area across the cortex and larger basal ganglia volumes. B. Compared to healthy individuals, psychosis subtype 2 demonstrated widespread lower surface area and cortical thickness, and smaller subcortical volumes. (Hill, L.D., et al. Subtyping psychotic disorders using a data-driven approach reveals divergent cortical and cellular signatures. Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03774-2. Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0/. Rights and Permissions: https://tinyurl.com/2e9nxeah.)
August 27, 2026

Brain scan method may improve diagnosis, treatment of psychosis

The study suggests that heterogeneity, or the wide range of symptoms, treatment responses and long-term outcomes observed in patients with various forms of psychosis, may reflect separate illness mechanisms and developmental pathways.

(iStock)
August 26, 2026

Vanderbilt Health receives $3.4 million grant to advance breast cancer imaging

MR cytometry is a magnetic resonance imaging technology pioneered by Vanderbilt Health investigators that provides information about tumor microstructure which cannot be obtained from conventional MRI.

Mónica Santisteban, PhD
August 21, 2026

Vanderbilt Health’s Mónica Santisteban to be honored by the American Heart Association

The recognition honors her research that has helped define how high blood pressure can contribute to cognitive impairment and Alzheimer’s disease.

August 18, 2026

Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.

August 18, 2026

Vanderbilt Health’s Annet Kirabo to receive major award for hypertension research 

The award will be presented Oct. 10 during the American Heart Association’s Hypertension Scientific Session in Arlington, Virginia.